Multi-Gene Expression Test Helps Rule Out Thyroid Surgery In Large Study

Presented and published study provides strong validation for use of Veracyte’s Afirma gene expression classifier in assessing patients with potential thyroid cancer.

More from Clinical Trials

More from R&D